 |
 |

Therapies for Benign Prostatic Hyperplasia
John Concato, MD, MPH;
Ralph I. Horwitz, MD;
Alvan R. Feinstein, MD;
JoAnn G. Elmore, MD;
Stephen F. Schiff, MD
Yale University School of Medicine New Haven, Conn
JAMA. 1993;269(7):867.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.
—We are responding to the letter by Roos et al.1 Roos et al2 previously reported that men with benign prostatic hyperplasia had higher mortality after transurethral resection of the prostate (TURP) than after open prostatectomy. Investigating the survival of patients with benign prostatic hyperplasia at Yale-New Haven Hospital, we found that the increased mortality after TURP was attributable to patients' being older and sicker at the time of surgery.3 In their subsequent letter in JAMA, Roos et al made four main comments.
First, the authors referred to a trial in which 5-year mortality was higher after TURP (9/43 patients) than after open prostatectomy (2/32 patients).4 Roos et al report that the difference in proportions was statistically significant using a one-tail Student's t test, although the trial investigators did not conclude that TURP was responsible for the higher mortality. The authors did not discuss
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|